Objective: Verify the clinical effect of Ganciclovir Eye Drops.
目的：验证更昔洛韦滴眼液的临床应用效果。
Conclusions 0.2% ganciclovir in-situ gelling eye drops significantly increases the drug penetration into cornea and aqueous humor, and prolongs the residence time in cornea and aqueous humor.
结论更昔洛韦原位胶化滴眼液同一般滴眼液相比，明显延长药物在眼部的滞留时间，增加角膜组织和房水中的药物浓度。
Conclusions 0.2% ganciclovir in-situ gelling eye drops significantly increases the drug penetration into cornea and aqueous humor, and prolongs the residence time in cornea and aqueous humor.
结论更昔洛韦原位胶化滴眼液同一般滴眼液相比，明显延长药物在眼部的滞留时间，增加角膜组织和房水中的药物浓度。
应用推荐